As of April 16, 2025, Assertio Therapeutics (ASRT) has a market cap of $60.280 million USD. According to our data, Assertio Therapeutics is ranked No.7935 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $60.28 M |
-27.43%
|
Dec 31, 2024 | $83.07 M |
-18.69%
|
Dec 29, 2023 | $0.10 B |
-75.12%
|
Dec 30, 2022 | $0.41 B |
97.25%
|
Dec 31, 2021 | $0.21 B |
51.39%
|
Dec 31, 2020 | $0.14 B |
-71.20%
|
Dec 31, 2019 | $0.48 B |
-65.37%
|
Dec 31, 2018 | $1.38 B |
-55.16%
|
Dec 29, 2017 | $3.07 B |
-55.33%
|
Dec 30, 2016 | $6.88 B |
-0.61%
|
Dec 31, 2015 | $6.92 B |
12.54%
|
Dec 31, 2014 | $6.15 B |
52.27%
|
Dec 31, 2013 | $4.04 B |
70.92%
|
Dec 31, 2012 | $2.36 B |
19.50%
|
Dec 30, 2011 | $1.98 B |
-18.55%
|
Dec 31, 2010 | $2.43 B |
89.85%
|
Dec 31, 2009 | $1.28 B |
103.03%
|
Dec 31, 2008 | $0.63 B |
-49.39%
|
Dec 31, 2007 | $1.25 B |
-5.51%
|
Dec 29, 2006 | $1.32 B |
-42.50%
|
Dec 30, 2005 | $2.29 B |
11.11%
|
Dec 31, 2004 | $2.06 B |
-23.84%
|
Dec 31, 2003 | $2.71 B |
254.50%
|
Dec 31, 2002 | $0.76 B |
-71.01%
|
Dec 31, 2001 | $2.64 B |
57.71%
|
Dec 29, 2000 | $1.67 B |
-27.08%
|
Dec 31, 1999 | $2.29 B |
-23.81%
|
Dec 31, 1998 | $3.01 B |
85.29%
|
Dec 31, 1997 | $1.62 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Supernus Pharmaceuticals
SUPN
|
$1.76 B |
-0.000 M
|
![]() USA
|
![]() Pacira Biosciences
PCRX
|
$1.15 B |
-0.000 M
|
![]() USA
|
![]() Amneal Pharmaceuticals
AMRX
|
$3.34 B |
1.091 B
|
![]() USA
|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
![]() Israel
|
![]() Bausch Health
BHC
|
$1.67 B |
-0.000 M
|
![]() Canada
|
![]() Jazz Pharmaceuticals
JAZZ
|
$6.25 B |
0.000 M
|
![]() Ireland
|
![]() Alkermes
ALKS
|
$4.61 B |
-0.000 M
|
![]() Ireland
|
Market Cap | = | ASRT Stock Price | * | ASRT Shares Outstanding |
= | $0.63 | * | 95.77 M | |
= | $60.28 M |